Monopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Down 21.6% in May
Monopar Therapeutics Inc. (NASDAQ:MNPR – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 62,600 shares, a decrease of 21.6% from the May 15th total of 79,800 shares. Approximately 0.7% of the shares of the company are sold short. Based […]
More Stories
‘WE GOT HIM!’: Trump Says US Forces Rescue 2nd Airman Downed in Iran
By Ryan Morgan U.S. forces have successfully rescued a second U.S. airman whose F-15 Strike Eagle fighter jet was shot...
Monthly Payments for Homes Increased 1st Time in 6 Months
By Naveen Athrappully The median monthly mortgage payment in the United States hit $2,742 for the four weeks ending March...
Trump’s 3D Chess: How President Trump Is Checkmating China and Russia by Toppling Their Oil Proxies in Venezuela, Cuba, and Iran
By Stephen Zogopoulos, USNN World News In the rarefied world of grand strategy, true masters don’t play on a flat...
Iran Vows Lasting Grip on Strait of Hormuz After War
By Tom Ozimek Iran has signaled that it intends to exert lasting control over the Strait of Hormuz—the world’s most...
Trump Signs Memo to Pay All DHS Employees During Shutdown
By Troy Myers President Donald Trump on Friday signed a memorandum directing the Department of Homeland Security (DHS) to pay...
Best Photo Editing Apps in 2026: Features, Pricing, and Limitations
Finding the best photo editing app in 2026 has become difficult. With several Android and iOS editing tools available in...